Medivir: Birinapant ASCO 2019 presentation
Research Note
2019-06-04
15:46
The oral presentation of the phase I birinapant combination trial at ASCO 2019 provided some new encouraging data. We look forward to further data later this year and reiterate our base case fair value of SEK 29.
KP
Klas Palin
Disclosures and disclaimers